Two Sigma Investments’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Two Sigma Investments's BEAM Position: Q3 2026 in Review
Two Sigma Investments increased its Beam Therapeutics (BEAM) stake by 18% in Q3 2026, buying an estimated $7.03M and bringing the position to 1,640,815 shares worth $40.1M. The position accounts for 0.03% of the portfolio, ranked #642.
Two Sigma Investments first reported a position in BEAM in Q1 2021 and has held it in 20 quarters since. The position peaked at $47.6M in Q2 2026. 263 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Two Sigma Investments held 1,640,815 shares of Beam Therapeutics worth $40.1M as of Q3 2026.
- Two Sigma Investments bought 252,588 Beam Therapeutics shares in Q3 2026, an estimated $7.03M.
- Beam Therapeutics made up 0.03% of Two Sigma Investments's portfolio in Q3 2026, its #642 holding.
- Two Sigma Investments first reported a position in Beam Therapeutics in Q1 2021 and has held it in 20 quarters since.
- Two Sigma Investments's Beam Therapeutics position peaked at $47.6M in Q2 2026.
- 263 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.